Long-term outcomes of pediatric living donor liver transplantation at a single institution

Pediatric Transplantation

Volumn 14, Issue 7, 2010, Pages 870-878

  Oh, Seak Hee ^a   Kim, Kyung Mo ^a   Kim, Dae Yeon ^a   Lee, Yeoun Joo ^a   Rhee, Kang Won ^a   Jang, Joo Young ^a   Chang, Soo Hee ^a   Lee, Sun Youn ^a   Kim, Joon Sung ^a   Choi, Bo Hwa ^a   Park, Sung Jong ^a   Yoon, Chong Hyun ^a   Ko, Gi Young ^b   Sung, Kyu Bo ^b   Hwang, Gyu Sam ^b   Choi, Kyu Taek ^b   Yu, Eunsil ^b   Song, Gi Won ^b   Ha, Tae Yong ^b   Moon, Deok Bog ^b   Ahn, Chul Soo ^b   Kim, Ki Hun ^b   Hwang, Shin ^b   Park, Kwang Min ^b   Lee, Young Joo ^b   Lee, Sung Gyu ^b   more..

^a University of Ulsan   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

children; living donor liver transplantation; outcome

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS;

ADOLESCENT; ARTICLE; BILE DUCT ATRESIA; CHILD; CHRONIC GRAFT REJECTION; DEMOGRAPHY; DRUG PULSE THERAPY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; INFANT; LIVER FAILURE; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; SURVIVAL RATE; THROMBOSIS; TREATMENT RESPONSE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT SURVIVAL; HUMANS; INFANT; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; PEDIATRICS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 78349295672     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01357.x     Document Type: Article

References (39)

1. Starzl TE, Marchioro TL, Vonkaulla KN, et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963: 117: 659-676.
2. Otte JB,. History of pediatric liver transplantation. Where are we coming from? Where do we stand? Pediatr Transplant 2002: 6: 378-387.
3. Ozawa K, Uemoto S, Tanaka K, et al. An appraisal of pediatric liver transplantation from living relatives. Initial clinical experiences in 20 pediatric liver transplantations from living relatives as donors. Ann Surg 1992: 216: 547-553.
4. Emre S,. Living-donor liver transplantation in children. Pediatr Transplant 2002: 6: 43-46.
5. Ueda M, Oike F, Ogura Y, et al. Long-term outcomes of 600 living donor liver transplants for pediatric patients at a single center. Liver Transpl 2006: 12: 1326-1336.
6. Lee SG, Lee YJ, Park KM, et al. Living related donor liver transplantation: The Seoul experience. Transplant Proc 1996: 28: 2383-2384.
7. Hwang S, Lee SG, Lee YJ, et al. Lessons learned from 1,000 living donor liver transplantations in a single center: How to make living donations safe. Liver Transpl 2006: 12: 920-927.
8. Jain A, Mazariegos G, Kashyap R, et al. Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation 2002: 73: 941-947.
9. Kim JS, Groteluschen R, Mueller T, et al. Pediatric transplantation: The Hamburg experience. Transplantation 2005: 79: 1206-1209.
10. Farmer DG, Venick RS, Mcdiarmid SV, et al. Predictors of outcomes after pediatric liver transplantation: An analysis of more than 800 cases performed at a single institution. J Am Coll Surg 2007: 204: 904-906.
11. Mcdiarmid SV, Jordan S, Kim GS, et al. Prevention and preemptive therapy of posttransplant lymphoproliferative disease in pediatric liver recipients. Transplantation 1998: 66: 1604-1611.
12. Mcdiarmid SV,. The use of tacrolimus in pediatric liver transplantation. J Pediatr Gastroenterol Nutr 1998: 26: 90-102.
13. Freeman RB, Wiesner RH, Harper A, et al. The new liver allocation system: Moving toward evidence-based transplantation policy. Liver Transp 2002: 8: 851-858.
14. Wiesner RH,. MELD/PELD and the allocation of deceased donor livers for status 1 recipients with acute fulminant hepatic failure, primary nonfunction, hepatic artery thrombosis, and acute Wilsons disease. Liver Transpl 2004: 10 (Suppl. 2): S17-S22.
15. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988: 16: 128-140.
16. Ljungman P, Griffiths P, Paya C,. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002: 34: 1094-1097.
17. Holmes RD, Sokol RJ,. Epstein-Barr virus and post-transplant lymphoproliferative disease. Pediatr Transplant 2002: 6: 456-464.
18. Demetris A, Adams D, Bellamy C, et al. Update of the International Banff Schema for Liver Allograft Rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel. Hepatology 2000: 31: 792-799.
19. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999: 17: 3835-3849.
20. Chen CL, Concerjero A, Wangang CC, et al. Living donor liver transplantation for biliary atresia: A single-center experience with first 100 cases. Am J Transplant 2006: 6: 2672-2679.
21. Shepherd RW, Turmelle Y, Nadler M, et al. Risk factors for rejection and infection in pediatric liver transplantation. Am J Transplant 2008: 8: 396-403.
22. Mcdiarmid SV, Anand R, Lindblad AS,. Studies of pediatric liver transplantation: 2002 update. An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada. Pediatr Transplant 2004: 8: 284-294.
23. Jain A, Mazariegos G, Pokharna R, et al. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: A long-term analysis. Transplantation 2003: 75: 1020-1025.
24. Jang JY, Kim KM, Lee YJ, et al. Quantitative Epstein-Barr virus viral load monitoring in pediatric liver transplantation. Transplant Proc 2008: 40: 2546-2548.
25. Rela M, Muiesan P, Bhatnagar V, et al. Hepatic artery thrombosis after liver transplantation in children under 5 years of age. Transplantation 1996: 61: 1355-1357. (Pubitemid 26152825)
26. Stringer MD, Marshall MM, Muiesan P, et al. Survival and outcome after hepatic artery thrombosis complicating pediatric liver transplantation. J Pediatr Surg 2001: 36: 888-891.
27. Chardot C, Herrera JM, Debray D, et al. Portal vein complications after liver transplantation for biliary atresia. Liver Transpl Surg 1997: 3: 351-358.
28. Buell JF, Funaki B, Cronin DC, et al. Long-term venous complications after full-size and segmental pediatric liver transplantation. Ann Surg 2002: 236: 658-666.
29. Ko GY, Sung KB, Lee S, et al. Stent placement for the treatment of portal vein stenosis or occlusion in pediatric liver transplant recipients. J Vasc Interv Radiol 2007: 18: 1215-1221.
30. Carnevale FC, Machado AT, Moreira AM, et al. Midterm and long-term results of percutaneous endovascular treatment of venous outflow obstruction after pediatric liver transplantation. J Vasc Interv Radiol 2008: 19: 1439-1448.
31. Wallot MA, Mathot M, Janssen M, et al. Long-term survival and late graft loss in pediatric liver transplant recipients-a 15-year single-center experience. Liver Transpl 2002: 8: 615-622.
32. Mcdiarmid SV, Merionerion RM, Dykstaraykstra DM, et al. Selection of pediatric candidates under the PELD system. Liver Transpl 2004: 10 (Suppl. 2): S23-S30.
33. Barshes NR, Lee TC, Udell IW, et al. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients. Liver Transpl 2006: 12: 475-480.
34. Cochran JB, Losek JD,. Acute liver failure in children. Pediatr Emerg Care 2007: 23: 129-135.
35. Tanaka A, Tanaka K, Tokuka A, et al. Graft size-matching in living related partial liver transplantation in relation to tissue oxygenation and metabolic capacity. Transpl Int 1996: 9: 15-22.
36. Kiuchi T, Kasahara M, Uryuhara K, et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 1999: 67: 321-327.
37. Egawa H, Oike F, Buhler L, et al. Impact of recipient age on outcome of ABO incompatible living-donor liver transplantation. Transplantation 2004: 77: 403-411.
38. Egawa H, Ohdan H, Haga H, et al. Current status of liver transplantation across ABO blood-type barrier. J Hepatobiliary Pancreat Surg 2008: 15: 131-138.
39. Kim JS, Kim KM, Ko JK, et al. Intrapulmonary shunt in the course of pediatric liver transplantation. Transplant Proc 2008: 40: 2512-2514.